Charles River Laboratories International (CRL) Enterprise Value: 2009-2025
Historic Enterprise Value for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $7.1 billion.
- Charles River Laboratories International's Enterprise Value fell 29.05% to $7.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 billion, marking a year-over-year decrease of 29.60%. This contributed to the annual value of $9.4 billion for FY2024, which is 21.34% down from last year.
- As of Q3 2025, Charles River Laboratories International's Enterprise Value stood at $7.1 billion, which was down 1.11% from $7.2 billion recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Enterprise Value ranged from a high of $22.9 billion in Q3 2021 and a low of $7.1 billion during Q3 2025.
- In the last 3 years, Charles River Laboratories International's Enterprise Value had a median value of $10.1 billion in 2024 and averaged $9.8 billion.
- Its Enterprise Value has fluctuated over the past 5 years, first spiked by 138.35% in 2021, then plummeted by 59.06% in 2022.
- Over the past 5 years, Charles River Laboratories International's Enterprise Value (Quarterly) stood at $18.4 billion in 2021, then plummeted by 40.93% to $10.9 billion in 2022, then increased by 9.28% to $11.9 billion in 2023, then declined by 21.34% to $9.4 billion in 2024, then declined by 29.05% to $7.1 billion in 2025.
- Its Enterprise Value was $7.1 billion in Q3 2025, compared to $7.2 billion in Q2 2025 and $7.8 billion in Q1 2025.